These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39119106)

  • 1. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer.
    Feng S; Ning L; Zhang H; Wang Z; Lu Y
    PeerJ; 2024; 12():e17861. PubMed ID: 39119106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer.
    Chen X; Sun H; Yang C; Wang W; Lyu W; Zou K; Zhang F; Dai Z; He X; Dong H
    PeerJ; 2024; 12():e17419. PubMed ID: 38912044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.
    Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF
    Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
    Ren H; Shen X; Xie M; Guo X
    Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma.
    Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM
    World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seven-nuclear receptor-based prognostic signature in breast cancer.
    Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
    Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
    Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
    Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
    Yu Z; Zhu Y; Ji J
    Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
    Chen X; Zheng J; Zhuo ML; Zhang A; You Z
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33179733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a prognostic model for breast cancer based on moonlighting genes.
    Zhang M; Zhang D; Wang Q; Lin G
    Hum Mol Genet; 2024 Jun; 33(12):1023-1035. PubMed ID: 38491801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer.
    Liu J; Miao X; Yao J; Wan Z; Yang X; Tian W
    Aging (Albany NY); 2024 Feb; 16(3):2934-2952. PubMed ID: 38329437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration.
    Tang C; Qin L; Li J
    Medicine (Baltimore); 2023 Oct; 102(43):e35732. PubMed ID: 37904416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.